Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
出版年份 2015 全文链接
标题
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
作者
关键词
Colorectal cancer, Guideline, Surgery, Chemotherapy, Endoscopy, Radiotherapy
出版物
International Journal of Clinical Oncology
Volume 20, Issue 2, Pages 207-239
出版商
Springer Nature
发表日期
2015-03-17
DOI
10.1007/s10147-015-0801-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
- (2013) Jeff Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Long-term Outcomes After Resection for Submucosal Invasive Colorectal Cancers
- (2012) Hiroaki Ikematsu et al. GASTROENTEROLOGY
- GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
- (2012) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
- (2012) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
- (2012) Massimo Brunetti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
- (2012) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
- (2012) Samuel Y. Ngan et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
- (2012) Jean-Pierre Gérard et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
- (2012) Ralf-Dieter Hofheinz et al. LANCET ONCOLOGY
- Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
- (2012) Claus Rödel et al. LANCET ONCOLOGY
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- A Systematic Review of Clinical Response and Survival Outcomes of Downsizing Systemic Chemotherapy and Rescue Liver Surgery in Patients with Initially Unresectable Colorectal Liver Metastases
- (2011) Vincent W. T. Lam et al. ANNALS OF SURGICAL ONCOLOGY
- Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: A retrospective multicenter study
- (2011) Takahisa Matsuda et al. CANCER SCIENCE
- MID-TERM PROGNOSIS AFTER ENDOSCOPIC RESECTION FOR SUBMUCOSAL COLORECTAL CARCINOMA: SUMMARY OF A MULTICENTER QUESTIONNAIRE SURVEY CONDUCTED BY THE COLORECTAL ENDOSCOPIC RESECTION STANDARDIZATION IMPLEMENTATION WORKING GROUP IN JAPANESE SOCIETY FOR CANCER O
- (2011) Shiro Oka et al. Digestive Endoscopy
- First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
- (2011) Claus-Henning Köhne et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- GRADE guidelines: 9. Rating up the quality of evidence
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 8. Rating the quality of evidence—indirectness
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 5. Rating the quality of evidence—publication bias
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Population-Based Study of Competing Mortality in Head and Neck Cancer
- (2011) Brent S. Rose et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
- (2011) Carlo Aschele et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
- (2011) Willem van Gijn et al. LANCET ONCOLOGY
- GRADE guidelines: 2. Framing the question and deciding on important outcomes
- (2010) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
- (2010) Niall C. Tebbutt et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
- (2010) Jean-Pierre Gérard et al. JOURNAL OF CLINICAL ONCOLOGY
- Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
- (2010) Kei Muro et al. LANCET ONCOLOGY
- American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer
- (2009) Sandra L. Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
- (2008) M. L. Rothenberg et al. ANNALS OF ONCOLOGY
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
- (2008) Emmanuel Mitry et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C Study
- (2008) Charles S. Fuchs et al. JOURNAL OF CLINICAL ONCOLOGY
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection
- (2008) Shinji Tanaka et al. JOURNAL OF GASTROENTEROLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- What is “quality of evidence” and why is it important to clinicians?
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now